90Y-labelled anti-CD66 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 90Y-labelled anti-CD66 antibody, covering 2023-10-03 to 2023-10-03. Get the full timeline:
Most recent: Clinical Trial Update: 90Y-labelled Anti-CD66 ab in Childhood High Risk Leukaemia [Phase 2]